Carbon ion therapy for ameloblastic carcinoma.

Area of Science:

• Oncology
• Radiation Oncology
• Head and Neck Cancer Research

Background:

• Ameloblastic carcinomas are rare, aggressive odontogenic tumors requiring multimodal treatment.
• Standard treatment involves surgical resection, often with adjuvant radiotherapy.
• Recurrence necessitates alternative therapeutic strategies.

Observation:

• A 71-year-old male patient with extensive local relapse of ameloblastic carcinoma was treated with carbon ion therapy.
• The patient had previously undergone surgery and adjuvant radiation.
• The patient was considered unfit for further extensive surgery.

Findings:

• Carbon ion therapy resulted in a complete remission at 6 weeks post-treatment.
• The treatment was well-tolerated, with only mild side effects reported.
• This indicates high efficacy and good tolerability of carbon ion therapy.

Implications:

• High-dose carbon ion radiation therapy is a promising alternative to extensive surgery for ameloblastic carcinoma.
• It is particularly beneficial for patients unfit for surgery or when resection is mutilating.
• This approach may improve outcomes and quality of life in recurrent cases.